Chauhan Neelima B
Research and Development, Veterans Affairs Chicago Health Care System-West Side VA Medical Center, and Department of NeuroAnesthesiology, University of Illinois at Chicago, Chicago, IL 60612, USA.
J Lipid Res. 2003 Nov;44(11):2019-29. doi: 10.1194/jlr.R300010-JLR200. Epub 2003 Sep 1.
Alzheimer's disease (AD) is characterized by the deposition of beta-amyloid (A beta) plaques derived from the amyloidogenic processing; of a transmembrane protein called beta-amyloid precursor protein (APP). In addition to the known genetic/sporadic factors that promote the formation of A beta, the composition and structural dynamics of the membrane are also thought to play a significant role in the amyloidogenic processing of APP that promotes seeding of A beta. This minireview reinforces the roles played by membrane dynamics, membrane microdomains, and cholesterol homeostasis in relation to amyloidogenesis, and reviews current strategies of lowering cholesterol in treating AD.
阿尔茨海默病(AD)的特征是由淀粉样前体蛋白(APP)这种跨膜蛋白的淀粉样生成过程产生的β-淀粉样蛋白(Aβ)斑块沉积。除了已知的促进Aβ形成的遗传/散发性因素外,膜的组成和结构动力学也被认为在促进Aβ种子形成的APP淀粉样生成过程中起重要作用。这篇综述强化了膜动力学、膜微区和胆固醇稳态在淀粉样蛋白生成方面所起的作用,并综述了目前在治疗AD中降低胆固醇的策略。